13 Jun AGM voting
Paris, France and Camberley, UK – 13 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM)...
01 Jun CTDA approval of PROmate® COVID-19 1 Gene and grant of CE mark for COVID-19 lateral flow self-test
Posted at 06:01h
in Uncategorized
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the approval of its PROmate® COVID-19 1G (q16) Real-Time PCR test (for use on its Q16 instrument),...
01 Jun Publication of Annual Report and AGM voting
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts ("Annual Report") for the year ended 31 December 2021 has...
13 May Notice of Annual General Meeting
Paris, France and Camberley, UK – 13 May 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting...
28 Apr Full year 2021 results and update on growth strategy
Full year revenue and EBITDA in line with market expectations despite challenging and changing COVID-19 testing marketLeveraging core capabilities to become a leading, global clinical diagnostics company targeting annual revenues...
26 Apr DHSC dispute update
Paris, France and Camberley, UK – 26 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with...
20 Apr Notice of Full Year 2021 Results and Investor Presentation
Paris, France and Camberley, UK – 20 April 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it will report its audited...
13 Apr Innovative automation supports laboratory testing workflow
Novacyt has unveiled the new CO-Prep™ Automated Liquid Handling System designed for use with the PROmate® COVID-19 assay workflows, which can also be used to support busy laboratories and private...
12 Apr Approval of second direct-to-PCR COVID-19 test in the UK under CTDA legislation
Paris, France and Camberley, UK – 12 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s PROmate® COVID-19 1G (q32)...
28 Mar Director/PDMR Shareholding
Paris, France and Camberley, UK – 25 March 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on...